A Study of Barzolvolimab in Patients With Prurigo Nodularis

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

NCT07266402 ·Status: RECRUITING ·Phase: PHASE3

Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

NCT07256392 ·Status: RECRUITING ·Phase: PHASE3

Study to Assess the Efficacy, Safety, and Tolerability of Vixarelimab in Reducing Pruritus in Prurigo Nodularis

NCT03816891 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Tolerability of Maximal Use Ruxolitinib Cream

NCT06213831 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)

NCT05755438 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess the Efficacy and Safety of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

NCT04501666 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN)

NCT05764161 ·Status: COMPLETED ·Phase: PHASE3

Study of Remibrutinib (LOU064) Efficacy and Safety and Exploration of Its Mechanism of Action in Participants With Chronic Urticaria

NCT06865651 ·Status: RECRUITING ·Phase: PHASE2

A Study to Investigate the Use of Benralizumab in Patients With Bullous Pemphigoid.

NCT04612790 ·Status: TERMINATED ·Phase: PHASE3

Rituximab in the Treatment of Patients With Bullous Pemphigoid

NCT00286325 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety and Efficacy of Nemolizumab in PN

NCT03181503 ·Status: COMPLETED ·Phase: PHASE2

A Long-term Study of Nemolizumab (CD14152) in Participants With Prurigo Nodularis (PN)

NCT04204616 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Use of KC706 for the Treatment of Pemphigus Vulgaris

NCT00606749 ·Status: COMPLETED ·Phase: PHASE2

A Study of PRN1008 in Adult Patients With Pemphigus Vulgaris

NCT02704429 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis

NCT06293053 ·Status: RECRUITING ·Phase: PHASE3

Deciphering IL-17-dependant Inflammatory Response in Bullous Pemphigoid

NCT06479018 ·Status: RECRUITING ·Phase: NA

A Study to Evaluate the Safety and Efficacy of Bermekimab in Patients With Moderate to Severe Atopic Dermatitis

NCT04021862 ·Status: COMPLETED ·Phase: PHASE2

Topical Ruxolitinib Evaluation in Immune-related Lichenoid Skin-Toxicities

NCT06399029 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Baricitinib for Cutaneous Dermatomyositis

NCT05361109 ·Status: WITHDRAWN ·Phase: PHASE2

An Extension Study of Long-term Efficacy, Safety and Tolerability of Remibrutinib in Chronic Spontaneous Urticaria Patients Who Completed Preceding Studies With Remibrutinib

NCT05513001 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa

NCT04762277 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and in Adults With Autoimmune Dermatological Diseases

NCT06342713 ·Status: RECRUITING ·Phase: PHASE1

A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease

NCT06388564 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Study to Investigate Efficacy, Safety, and Tolerability of Remibrutinib Compared With Placebo in Adults With CINDU Inadequately Controlled by H1-antihistamines

NCT05976243 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Compassionate Use of Dupilumab for Adult Patients With Bullous Pemphigoid

NCT05906706 ·Status: APPROVED_FOR_MARKETING